Mepacrine

Mepacrine
Clinical data
Trade names	Atabrine, Atebrin
AHFS/Drugs.com	Micromedex Detailed Consumer Information
ATC code	P01AX05 (WHO) QP51AX04 (WHO);
Pharmacokinetic data
Protein binding	80–90%
Elimination half-life	5–14 days
Identifiers
	IUPAC name (RS)-N′-(6-Chloro-2-methoxy-acridin-9-yl)-N,N-diethylpentane-1,4-diamine;
CAS Number	83-89-6 ;
PubChem CID	237;
DrugBank	DB01103 ;
ChemSpider	232 ;
UNII	H0C805XYDE;
KEGG	D08179;
ChEBI	CHEBI:8711 ;
ChEMBL	ChEMBL7568 ;
PDB ligand	QUN (PDBe, RCSB PDB);
CompTox Dashboard (EPA)	DTXSID7022627 ;
ECHA InfoCard	100.001.371
Chemical and physical data
Formula	C23H30ClN3O
Molar mass	399.96 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES CCN(CC)CCCC(C)Nc1c2ccc(cc2nc3c1cc(cc3)OC)Cl;
	InChI InChI=1S/C23H30ClN3O/c1-5-27(6-2)13-7-8-16(3)25-23-19-11-9-17(24)14-22(19)26-21-12-10-18(28-4)15-20(21)23/h9-12,14-16H,5-8,13H2,1-4H3,(H,25,26) ; Key:GPKJTRJOBQGKQK-UHFFFAOYSA-N ;
	(verify)

Mepacrine, also called quinacrine or by the trade names Atabrine or Atebrin, is a medication with several uses. It is related to chloroquine and mefloquine. Although available from compounding pharmacies, as of August 2020 approved formulations are not available in the United States.